we identified the targets of clinical covalent drugs using an optimized analytical platform-QTRP (Quantitative Thiol Reactivity Profiling), and aim to identify new targets for illuminating uncharacterized covalent mechanisms of action and for the repurposing of an existing drug as a covalent recruiter for targeted protein degradation